Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10301169 | 0.98 | MEN1 (0.40) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL14867188 | 0.98 | MEN1 (0.40) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL26921062 | 0.98 | TSHR (0.39) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL10029816 | 0.98 | TSHR (0.39) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL14867187 | 0.98 | MEN1 (0.40) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL10301180 | 0.97 | MEN1 (0.39) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL19822569 | 0.95 | TSHR (0.37) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL17617967 | 0.95 | MEN1 (0.40) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL12266699 | 0.93 | TSHR (0.46) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL25495227 | 0.92 | TSHR (0.37) | TSHRMEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240148-B1 | METHOD FOR LOW VOLUME SPRAY APPLICATION | BAYER AG (DE) | 2025-11-12 | — | — | EP | disclosed |
| US-20230295433-A1 | SILICONE EMULSION COMPOSITION AND FIBER TREATMENT AGENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11744789-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, a colored effect pigment and a sealing reagent III | HENKEL AG & CO. KGAA (US) | 2023-09-05 | — | — | US | disclosed |
| US-11654095-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, a chromophoric compound, a modified fatty acid ester and a sealing reagent II | HENKEL AG & CO. KGAA (DE) | 2023-05-23 | — | — | US | disclosed |
| US-11655341-B2 | Method for preparing a radical-polymerizable organopolysiloxane, a radiation-curable organopolysiloxane composition, and a release sheet | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-23 | — | — | US | disclosed |
| EP-3994993-A1 | LOW DRIFT, RAINFASTNESS, HIGH SPREADING AND ULV TANK MIX ADJUVANT FORMULATION | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3994981-A1 | METHOD FOR LOW VOLUME SPRAY APPLICATION | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3994995-A1 | LOW DRIFT, RAINFASTNESS, HIGH SPREADING, HIGH UPTAKE AND ULV TANK MIX ADJUVANT FORMULATION | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3994986-A1 | AGROCHEMICAL COMPOSITION WITH IMPROVED DRIFT AND SPREADING PROPERTIES | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3994994-A1 | LOW DRIFT, RAINFASTNESS, HIGH SPREADING, HIGH UPTAKE AND ULV TANK MIX ADJUVANT FORMULATION | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| US-20170216156-A1 | PERFORMANCE-ENHANCED ANTIPERSPIRANTS | HENKEL AG & CO. KGAA (DE) | 2017-08-03 | — | — | US | disclosed |
| US-9371458-B2 | Ink composition for ink jet recording and ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2016-06-21 | — | — | US | disclosed |
| US-8697101-B2 | Polysiloxane antimicrobials | BASF SE (DE) | 2014-04-15 | — | — | US | disclosed |
| US-20120061877-A1 | Hyrdophilic Surface Modification of Polydimethylsiloxane | UTAH STATE UNIVERSITY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120052374-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE BATTERY | SONY CORPORATION (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20110251417-A1 | Partially Hydrocarbon Group-Blocked (Poly)Glycerol-Modified Polysiloxane, Method For Producing The Same, And Cosmetic Composition Containing The Same | DOW TORAY CO., LTD. (JP) | 2011-10-13 | — | — | US | disclosed |
| US-8034891-B2 | Polyether-modified organopolysiloxane, diorganopolysiloxane-polyether block copolymer, their production methods, and cosmetic preparation | DOW CORNING TORAY COMPANY, LTD. (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20110110998-A1 | POLYSILOXANE ANTIMICROBIALS | BASF SE (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20100036062-A1 | Polyether-Modified Organopolysiloxane, Diorganopolysiloxane-Polyether Block Copolymer, Their Production Methods, and Cosmetic Preparation | DOW TORAY CO., LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20070026509-A1 | Novel surface-active polysiloxane photoinitiators | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251417-A1 | Partially Hydrocarbon Group-Blocked (Poly)Glycerol-Modified Polysiloxane, Method For Producing The Same, And Cosmetic Composition Containing The Same | PFAS, NOTUM, FGB | TSHR 4479/4885MEN1 4360/4885KMT2A 519/4885 |
| US-11654095-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, a chromophoric compound, a modified fatty acid ester and a sealing reagent II | FABP2, KRT18, FABP4 | TSHR 4852/4885MEN1 2991/4885KMT2A 654/4885 |
| US-11744789-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, a colored effect pigment and a sealing reagent III | KRT18, JUP, EPCAM | TSHR 4698/4885MEN1 673/4885KMT2A 2385/4885 |
| US-11655341-B2 | Method for preparing a radical-polymerizable organopolysiloxane, a radiation-curable organopolysiloxane composition, and a release sheet | MUS81, MSR1, H1-4 | TSHR 147/4885MEN1 490/4885KMT2A 1452/4885 |
| US-20110110998-A1 | POLYSILOXANE ANTIMICROBIALS | SIGMAR1, MSR1, TLR5 | TSHR 296/4885MEN1 4731/4885KMT2A 4067/4885 |
| US-20170216156-A1 | PERFORMANCE-ENHANCED ANTIPERSPIRANTS | ALOX5, ALKBH3, ALOX15 | TSHR 2758/4885MEN1 4525/4885KMT2A 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.